RIME KO significantly shortened the half‐life of MLL1 in ESCC cells, suggesting that RIME is essential for maintaining MLL1 stability (Figure 3H,I and Figure S3C,D). This evidence concerns the gene KMT2A and esophageal squamous cell carcinoma.